Rituximab, Cyclophosphamide, Dexamethasone (RCD) regimen induces cure in WSU-WM xenograft model and a partial remission in previously treated Waldenstrom's macroglobulinemia patient. [electronic resource]
Producer: 20030211Description: 405-10 p. digitalISSN:- 1061-186X
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Cell Division -- drug effects
- Cell Line
- Cyclophosphamide -- administration & dosage
- Dexamethasone -- administration & dosage
- Disease Models, Animal
- Drug Therapy, Combination
- Female
- Humans
- Mice
- Mice, Inbred ICR
- Mice, SCID
- Middle Aged
- Remission Induction
- Rituximab
- Waldenstrom Macroglobulinemia -- drug therapy
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Case Reports; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.